Sleep Apnea Therapy Monitoring (CPAP)
Those using a CPAP device should have it checked at least once yearly — pressure, mask and leakage change over time, especially after weight changes.
Patients with diagnosed obstructive sleep apnea (OSA) receive airway therapy — usually CPAP (Continuous Positive Airway Pressure), APAP (automatically adjusting pressure) or BiPAP (bi-level). This therapy is highly effective, but it requires regular monitoring and adjustment. Annual check-ups are standard in sleep medicine.
What is checked during monitoring
1. Therapy adherence (compliance)
Modern CPAP devices store usage data. We check:
- How many nights per week is the device used?
- How long per night is it worn (operating hours)?
- Are there trends in usage?
Good adherence (at least 4-5 nights per week, at least 5-6 hours per night) is critical for therapy success.
2. Residual AHI and residual events
Even with therapy, breathing pauses may still occur (residual AHI). This is checked and pressure settings are adjusted if needed.
3. Mask fit and leakage
Good mask fit is necessary for therapy effectiveness and comfort:
- Is the mask fitting properly and still comfortable?
- Are there leaks (air escaping)?
- Is a mask change needed?
4. Subjective sleep quality and well-being
Patients report:
- Has daytime somnolence improved?
- Are morning headaches gone?
- How is overall quality of life?
5. Cardiovascular risk factors
We regularly monitor:
- Blood pressure: Does it normalize with therapy?
- Weight: Changes in body mass index
- Metabolism: Glucose, lipids, kidney/liver function
Connection with weight reduction
The S3 Guideline of the German Society for Sleep Medicine (DGSM, AWMF 063-001)[1] emphasizes the central importance of weight reduction in overweight patients with OSA. Reason: Overweight is a major risk factor for sleep apnea.
Weight loss during CPAP therapy
Effective CPAP therapy improves metabolic conditions for weight reduction[2]:
- Normalization of sleep architecture leads to favorable leptin and ghrelin levels[4]
- Reduction of daytime somnolence enables more physical activity
- Improvement of insulin sensitivity and glucose metabolism[5]
Reduction of CPAP settings
The S3 Guideline[1] emphasizes: Even 10% weight loss can reduce AHI by 30-50%.[2] In the SURMOUNT-OSA study (2024), tirzepatide reduced AHI in obese sleep apnea patients by approximately 50%.[3] With significant weight loss, therefore, pressure can be reduced or CPAP discontinued. However, this requires:
- Repeat sleep medicine diagnostics (polygraphy)
- Confirmation that AHI is below normal range
- Long-term monitoring even after discontinuation
Therefore, we often link CPAP therapy with a structured obesity program for optimal long-term outcomes.
Annual check-ups are standard. New airway therapy requires close initial monitoring (after 2-4 weeks), then annually. All measures follow current guidelines.
References
- S3 Guideline Sleep-Related Breathing Disorders in Adults. AWMF Registry No. 063-001, German Society for Sleep Research and Sleep Medicine (DGSM), 2017.
- Peppard PE, Young T, Palta M et al. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000;284(23):3015–3021.
- Malhotra A, Grunstein RR, Gao L et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity (SURMOUNT-OSA). N Engl J Med. 2024;391(13):1193–1205.
- Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med. 2004;141(11):846–850.
- Reutrakul S, Van Cauter E. Sleep influences on obesity, insulin resistance, and risk of type 2 diabetes. Metabolism. 2018;84:56–66.
Address
Georg-Schumann-Straße 257
04159 Leipzig
Contact
Phone: 0341 5210871
Email: info@internist-wenzel.de